Accession Number: | 0000950103-21-005530 |
Date: | 2021-04-12 |
Issuer: | ROYALTY PHARMA PLC (RPRX) |
Original Submission Date: |
LLOYD GEORGE W.
C/O ROYALTY PHARMA PLC
110 EAST 59TH STREET
NEW YORK, NY 10022
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
CLASS A ORDINARY SHARES | 2021-04-12 | S | 89 | d | $42.32 | 63,924 | indirect | ||
CLASS A ORDINARY SHARES | 2021-04-12 | S | 360 | d | $42.32 | 255,898 | indirect | ||
CLASS A ORDINARY SHARES | 2021-04-12 | 0 | $0.00 | 3,000 | direct | ||||
CLASS A ORDINARY SHARES | 2021-04-12 | 0 | $0.00 | 273,960 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|